Lpl Financial LLC Global Blood Therapeutics, Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $110,775 - $233,107	3,419 New	3,419 $233,000
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $1.12 Million - $2.35 Million	-26,897 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $1.23 Million - $2.2 Million	26,897 New	26,897 $2.14 Million
Q3 2019 Nov 13, 2019	SELL	$45.35 - $57.91 $189,064 - $241,426	-4,169 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$52.6 - $63.29 $219,289 - $263,856	4,169 New	4,169 $219,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.